×
Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder PDF
$ 40.00
Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder PDF quantity
$ 40.00
×
Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Insomnia Symptoms With Subjective Short Sleep Duration in a Random Sample From the United Kingdom PDF
$ 40.00
Insomnia Symptoms With Subjective Short Sleep Duration in a Random Sample From the United Kingdom PDF quantity
$ 40.00
×
Reduction of Crime in First-Onset Psychosis: A Secondary Analysis of the OPUS Randomized Trial PDF
$ 40.00
Reduction of Crime in First-Onset Psychosis: A Secondary Analysis of the OPUS Randomized Trial PDF quantity
$ 40.00
×
Frequency and Correlates of Inappropriate Pediatric Psychiatric Emergency Room Visits PDF
$ 40.00
Frequency and Correlates of Inappropriate Pediatric Psychiatric Emergency Room Visits PDF quantity
$ 40.00
×
Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review PDF
$ 40.00
Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review PDF quantity
$ 40.00
×
Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures PDF
$ 40.00
Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures PDF quantity
$ 40.00
×
Association Between Lithium Use and Risk of Alzheimer's Disease PDF
$ 40.00
Association Between Lithium Use and Risk of Alzheimer's Disease PDF quantity
$ 40.00
×
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF
$ 40.00
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart